Stay updated on Safety & Efficacy of Tiragolumab Combo in Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Safety & Efficacy of Tiragolumab Combo in Lung Cancer Clinical Trial page.

Latest updates to the Safety & Efficacy of Tiragolumab Combo in Lung Cancer Clinical Trial page
- Check7 days agoChange DetectedThe record history now includes an added revision entry for v3.5.2 and a removed revision entry for v3.5.0.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe history now includes Revision: v3.5.0 and no longer lists Revision: v3.4.3.SummaryDifference0.1%

- Check36 days agoChange DetectedRecord History shows termination of the study and posting of results, with updated status entries (Results Posted) and related changes. The prior 'Completed' and 'Results Submitted' status entries were removed.SummaryDifference0.5%

- Check43 days agoChange DetectedA new revision v3.4.3 was added to the history, and revision v3.4.2 was removed.SummaryDifference0.1%

- Check57 days agoChange DetectedAdded results-related sections (Adverse Events, Outcome Measures, Baseline Characteristics, Participant Flow) and QC/status notes in the latest version. This expands access to core study data and documentation.SummaryDifference0.8%

- Check71 days agoChange DetectedAdded Revision: v3.4.2 to the history; removed the prior Notice about government funding/operating status and Revision: v3.4.1.SummaryDifference0.5%

Stay in the know with updates to Safety & Efficacy of Tiragolumab Combo in Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety & Efficacy of Tiragolumab Combo in Lung Cancer Clinical Trial page.